首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma
【2h】

Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma

机译:肿瘤坏死因子α是人类原始造血祖细胞增殖的有效协同因子可诱导对转化生长因子β的抗性但对干扰素γ无抵抗力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and transforming growth factor (TGF)-beta have all been shown to be specific inhibitors of early human hematopoiesis, we wanted to investigate the interactions of these three cytokines on very primitive human adult bone marrow CD34++CD38- hematopoietic progenitor cells, using a pre-colony-forming cell (pre-CFC) assay, which detects the effects of these cytokines on the initial phases of the differentiation of these primitive progenitors, which are unresponsive to interleukin (IL) 3 alone. Surprisingly, TNF-alpha was a very potent stimulator of the proliferation of CD34++CD38- cells and was the most potent synergistic factor for the IL-3-induced proliferation of these cells of all cytokines tested (IL-1, IL-6, granulocyte colony-stimulating factor, kit ligand). TNF-alpha was the only cytokine that, as a single added factor, induced substantial proliferation in CD34++CD38- cells in the presence of IL-3, except for kit ligand, which induced very limited proliferation. TNF-alpha, moreover, induced a high degree of resistance to the inhibitory effects of TGF-beta in a dose-dependent way. The inhibitory effects of IFN-gamma, however, were not affected by the presence of TNF-alpha. We hypothesize that in situations of the hematopoietic stress, TNF-alpha may abrogate the inhibitory effect of ambient TGF-beta in the bone marrow microenvironment to allow primitive stem cells to proliferate and differentiate in response to an increased demand for mature blood cells.
机译:由于肿瘤坏死因子(TNF)-α,干扰素(IFN)-γ和转化生长因子(TGF)-β均已被证明是人类早期造血作用的特异性抑制剂,因此,我们希望研究这三种细胞因子的相互作用。非常原始的人类成年骨髓CD34 ++ CD38-造血祖细胞,使用集落形成前细胞(pre-CFC)分析,可检测这些细胞因子对这些原始祖细胞分化初始阶段的影响,对单独的白介素(IL)3无反应。出人意料的是,TNF-α是CD34 ++ CD38-细胞增殖的非常有效的刺激物,并且是所有测试的细胞因子(IL-1,IL-6)由IL-3诱导这些细胞增殖的最有效的协同因子。 ,粒细胞集落刺激因子,试剂盒配体)。 TNF-α是唯一的细胞因子,作为单独添加的因子,在试剂盒配体除外的条件下,在IL-3存在下诱导CD34 ++ CD38-细胞大量增殖,除了试剂盒配体可诱导非常有限的增殖。而且,TNF-α以剂量依赖的方式诱导了对TGF-β抑制作用的高度抗性。但是,IFN-γ的抑制作用不受TNF-α的影响。我们假设在造血应激的情况下,TNF-α可能会消除骨髓微环境中周围TGF-β的抑制作用,以允许原始干细胞增殖和分化,以响应对成熟​​血细胞增加的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号